The increasing incidence of head and neck cancers in South Asia has been described as a global health crisis.1 Particularly in India, the high incidence of oral cancers is ascribed to the popularity of chewing “gutka” (a compound mixture of tobacco, acacia, and betel nut extracts). The problem of high oral cancer incidence is exacerbated, particularly in rural areas, by limited accessibility of early stage medical screening and imaging. Furthermore, the economic burden of late stage treatments such as complex surgical procedures and/or radiation therapy pose a further barrier in oral cancer management.2 Photodynamic therapy (PDT) has emerged as an alternative and noninvasive early stage anticancer treatment modality.3 PDT is a treatment in which a precursor or photosensitizer drug localized to the lesion sites is activated by light to generate singlet oxygen ()-mediated photocytotoxicity against cancer cells. Here, we used 5-aminolevulinic acid (ALA as Levulan®, DUSA, SUN Pharmaceuticals, Inc.), a precursor for the photoactive derivative protoporphyrin IX (PpIX).4 PpIX not only acts as a fluorescent probe but also imparts antitumor toxicity when activated by light. This dual functionality has been used successfully for image-guided treatment of various cancers, including those of the oral cavity.5,6 In clinical settings, PpIX fluorescence and photobleaching make it effective as a diagnostic as well as a treatment monitoring tool.7,8 Recently, a smartphone with fluorescence imaging capability has been used as a low-cost device for premalignant oral screening.8 The wide availability and popularity of smartphones, particularly in the developing countries, make this device promising as a low-cost, portable, and capable theragnostic cancer technology for global health.9–11 Building on previous preliminary findings,12 we report here an evaluation of this simple and low-cost fluorescence imaging approach for guidance and monitoring of PDT treatment in the clinic.
In this study, we carry out a pilot clinical evaluation of optical technologies for intraoral imaging and photodynamic therapy (PDT). The optical system for image-guided treatment of oral cancers described here is specifically engineered to address challenges faced in resource-limited clinics and is directly motivated by the public health crisis of oral squamous cell carcinoma (OSCC) in South Asia, where widespread chewing of tobacco-based products (e.g., “gutka”) drives truly alarming rates of oral cancer.1 In particular, in India, where there is a lack of widespread access to medical infrastructure for cancer management, the rate of new age-adjusted oral cancer cases is 36% (135,929), and the mortality rate is 42.4% (75,290 deaths). The World Health Organization projected that new oral cancer cases would increase to 209,000 (65%) and death would be 116,000 (65%) in India by 2040.2 Due to a lack of routine oral examination and timely biopsy, late-stage diagnosis is the norm in India, with 70% of cases presenting at stage III-IV.3 As a result, even those patients in rural areas who undergo conventional treatment with surgery and/or chemotherapy show a 5-year survival rate of .4 Clearly, there is an urgent need for new technologies that can help enable timely diagnosis and treatment of oral malignancy in challenging, resource-limited rural clinics. Such technologies must be specifically engineered to be produced at low cost, portable, easy to use, and functional in settings with limited infrastructure. In the present report, we demonstrate the integration of previously reported low-cost technology for PDT with an intraoral optical imaging probe previously validated for oral cancer detection and adapted here for image guidance of PDT.5–7
1 May 2020 in Archives of Biochemistry and Biophysics
Purpose: The present study investigates the psychological factors impacting female cancer patients receiving radiotherapy and the individuals providing care for them, within a sociocultural environment that frequently marginalizes and depends on women. This research highlights a strategy for cancer care that may enhance results for both patients and caregivers by attending to psychosocial needs. The primary objectives are to measure the levels of anxiety, depression, quality of life, and perceived stress in both patients and caregivers, as well as to determine how psychosocial counseling affects these factors.Methods: It was a single-group pre-post observational study. Before starting radiotherapy, assessment of various psychosocial factors was done in female cancer patients and their respective caregivers. Psychosocial counseling sessions were conducted at weekly intervals during radiotherapy. At the 6th week after radiotherapy, assessment of same psychosocial factors was done again in both the patients as well as their caregivers.Results: The results show that both patients and caregivers had serious psychological disorders, such as anxiety, depression, perceived stress, and decreased quality of life. Psychosocial modulation was associated with improvement in quality of life measures like overall health and emotional and physical functioning.Conclusion: The findings highlight how crucial it is to include psychological support in radiotherapy regimens. Despite limitations of the study, such as its exclusive focus on female patients, the results highlight the need to provide clinical staff with psycho-oncological training. The study recommends further investigation to ascertain the long-term effects of psychological health on treatment compliance and patient survival.